Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why BeiGene Soared 56.6% In July

TheMotleyFool 
0 0 09.08.17
Why BeiGene Soared 56.6% In JulyPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
 
Why BeiGene Soared 56.6% In July

After inking a collaboration agreement with biotech powerhouse Celgene (NASDAQ: CELG), shares in BeiGene Ltd. (NASDAQ: BGNE) rocketed 56.6% higher last month, according to S&P Global Market Intelligence.

Celgene loves locking up promising drugs in the pipeline of smaller peers, especially when those drugs could get to market relatively quickly.

IMAGE SOURCE: GETTY IMAGES.

Continue reading


Source: Fool.com

Merck & Co. Inc. Stock

€114.82
1.660%
There is an upward development for Merck & Co. Inc. compared to yesterday, with an increase of €1.88 (1.660%).
With 25 Buy predictions and not a single Sell prediction Merck & Co. Inc. is an absolute favorite of our community.
With a target price of 121 € there is a slightly positive potential of 5.38% for Merck & Co. Inc. compared to the current price of 114.82 €.
Show more
Like: 0
MRK
Share

Comments

Not a member yet? Sign up for free!